CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling

BACKGROUND: The correlation between elevated T-cell infiltration and improved survival of ovarian cancer (OvCa) patients suggests that endogenous tumor-infiltrating lymphocytes (TIL) possess some degree of antitumor activity that can be harnessed for OvCa immunotherapy. We previously optimized a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fix, Samantha M, Forget, Marie-Andrée, Sakellariou-Thompson, Donastas, Wang, Yunfei, Griffiths, Tamara M, Lee, Minjung, Haymaker, Cara L, Dominguez, Ana Lucía, Basar, Rafet, Reyes, Christopher, Kumar, Sanjay, Meyer, Larissa A, Hwu, Patrick, Bernatchez, Chantale, Jazaeri, Amir A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330322/
https://www.ncbi.nlm.nih.gov/pubmed/35882447
http://dx.doi.org/10.1136/jitc-2021-003750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330322/
https://www.ncbi.nlm.nih.gov/pubmed/35882447
http://dx.doi.org/10.1136/jitc-2021-003750

Ejemplares similares